PT Maja Agung Latexindo Tbk (IDX:SURI)
Indonesia · Delayed Price · Currency is IDR 77.00
-1.00 (-1.28%)
Apr 29, 2026, 9:11 AM WIB
IDX:SURI Revenue
In the year 2025, PT Maja Agung Latexindo Tbk had annual revenue of 150.24B IDR with 28.77% growth. PT Maja Agung Latexindo Tbk had revenue of 37.19B in the quarter ending December 31, 2025, a decrease of -9.12%.
Revenue
150.24B
Revenue Growth
+28.77%
P/S Ratio
3.29
Revenue / Employee
1.05B
Employees
143
Market Cap
494.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 150.24B | 33.57B | 28.77% |
| Dec 31, 2024 | 116.67B | 34.95B | 42.77% |
| Dec 31, 2023 | 81.72B | -11.61B | -12.44% |
| Dec 31, 2022 | 93.33B | -244.80B | -72.40% |
| Dec 31, 2021 | 338.13B | 24.75B | 7.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 35.32T |
| PT Siloam International Hospitals Tbk | 12.85T |
| PT Mitra Keluarga Karyasehat Tbk | 5.37T |
| PT Sejahteraraya Anugrahjaya Tbk | 2.59T |
| PT Itama Ranoraya Tbk | 1.10T |
| PT Ikapharmindo Putramas Tbk | 377.10B |
| PT Indofarma Tbk | 206.24B |
| PT Diastika Biotekindo Tbk | 201.31B |